These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23915846)

  • 61. Role of ifosfamide in cervical cancer: an overview.
    Buda A; Dell'Anna T; Signorelli M; Mangioni C
    Oncology; 2003; 65 Suppl 2():63-6. PubMed ID: 14586151
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Chemotherapy: cisplatin combinations in cervical cancer-which is best?
    Holtz DO; Dunton CJ
    Nat Rev Clin Oncol; 2010 Feb; 7(2):74-5. PubMed ID: 20118975
    [No Abstract]   [Full Text] [Related]  

  • 63. 5-aza-2'-deoxycytidine in advanced or recurrent cancer of the uterine cervix.
    Vermorken JB; Tumolo S; Roozendaal KJ; Guastalla JP; Splinter TA; Renard J
    Eur J Cancer; 1991; 27(2):216-7. PubMed ID: 1709026
    [No Abstract]   [Full Text] [Related]  

  • 64. Cytotoxic chemotherapy for advanced or recurrent cervical cancer.
    Green JA; Lainakis G
    Ann Oncol; 2006 Sep; 17 Suppl 10():x230-2. PubMed ID: 17018730
    [No Abstract]   [Full Text] [Related]  

  • 65. Treatment of recurrent cervical adenocarcinoma with BMS-247550, an epothilone B analog.
    Agrawal M; Edgerly M; Fojo T; Kotz H
    Gynecol Oncol; 2003 Jul; 90(1):96-9. PubMed ID: 12821348
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Chemotherapy in advanced primary and recurrent cervical carcinoma.
    Choo YC
    Int J Gynaecol Obstet; 1982 Oct; 20(5):417-23. PubMed ID: 6128275
    [No Abstract]   [Full Text] [Related]  

  • 67. Second-line treatment of ovarian cancer.
    Markman M; Bookman MA
    Oncologist; 2000; 5(1):26-35. PubMed ID: 10706647
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Systemic therapy in cervical cancer: 30 years in review.
    Liontos M; Kyriazoglou A; Dimitriadis I; Dimopoulos MA; Bamias A
    Crit Rev Oncol Hematol; 2019 May; 137():9-17. PubMed ID: 31014518
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A selective policy in follow-up for bowel cancer.
    Ross PJ; Cunningham D
    Lancet; 1998 Jun; 351(9119):1891-2. PubMed ID: 9652702
    [No Abstract]   [Full Text] [Related]  

  • 70. New Drug Treats Cervical Cancer.
    Aschenbrenner DS
    Am J Nurs; 2022 Jan; 122(1):21. PubMed ID: 34941590
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A pan-HER-targeted approach for recurrent or late-stage cervical cancer therapy: mechanisms, recent advances, and clinical prospects.
    Liu Y; An Q; Zhao X
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4123-4131. PubMed ID: 32373948
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Chemotherapy in the treatment of advanced pelvic malignant disease with special reference to ovarian cancer.
    Limburg H; Heckmann U
    J Obstet Gynaecol Br Commonw; 1968 Dec; 75(12):1246-55. PubMed ID: 5702360
    [No Abstract]   [Full Text] [Related]  

  • 73. An overview of the management of recurrent breast cancer.
    Burnet K
    Int J Palliat Nurs; 2000; 6(7):318-9, 322-30. PubMed ID: 11309903
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Current and potential treatments for cervical cancer.
    Yee GP; de Souza P; Khachigian LM
    Curr Cancer Drug Targets; 2013 Feb; 13(2):205-20. PubMed ID: 23259831
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Vinorelbine for recurrent adenocarcinoma-like salivary gland malignancies.
    Airoldi M; Bumma C; Bertetto O; Riella AM; Gabriele P; Succo G; Bussi M
    Eur J Cancer B Oral Oncol; 1996 May; 32B(3):213-4. PubMed ID: 8762881
    [No Abstract]   [Full Text] [Related]  

  • 76. Topoisomerase-I inhibitors in gynaecologic tumours.
    Verschraegen CF; Kudelka AP; Kavanagh JJ
    Ann Acad Med Singap; 1998 Sep; 27(5):683-7. PubMed ID: 9919340
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Chemotherapy of testicular cancer].
    Krege S; Hartmann JT; Rübben H
    Urologe A; 2006 May; 45(5):600-4. PubMed ID: 16612645
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Combined chemotherapy-radiation therapy recommended for invasive cervical cancer.
    Am J Health Syst Pharm; 1999 Apr; 56(8):702, 705. PubMed ID: 10326610
    [No Abstract]   [Full Text] [Related]  

  • 79. Recent breakthroughs in the management of locally advanced and recurrent/metastatic cervical cancer.
    García E; Ayoub N; Tewari KS
    J Gynecol Oncol; 2024 Jan; 35(1):e30. PubMed ID: 38072400
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Beyond angiogenesis blockade: targeted therapy for advanced cervical cancer.
    Eskander RN; Tewari KS
    J Gynecol Oncol; 2014 Jul; 25(3):249-59. PubMed ID: 25045438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.